Prognostic implications of non-invasive vascular function tests in high-risk atherosclerosis patients

Circulation Journal

Volumn 80, Issue 4, 2016, Pages 1034-1040

  Kusunose, Kenya ^a   Sato, Mitsuyo ^a   Yamada, Hirotsugu ^a   Saijo, Yoshihito ^a   Bando, Mika ^a   Hirata, Yukina ^a   Nishio, Susumu ^a   Hayashi, Shuji ^a   Sata, Masataka ^a  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cardiovascular event; Endothelial function; Kidney function; Vascular function

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR MALFORMATION; CORONARY ARTERY DILATATION; EVALUATION AND FOLLOW UP; FEMALE; FRAMINGHAM RISK SCORE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PULSE WAVE; BLOOD; CLINICAL TRIAL; KIDNEY; METABOLISM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; RISK FACTORS;

EID: 84961625684     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-1356     Document Type: Article

References (36)

1. Alpert JS. Cardiology patient page: What you need to know if you have coronary artery disease. Circulation 2011;124: e176-e178, doi:10.1161/CIRCULATIONAHA.111.019836.
2. Greenland P, Smith SC Jr, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: Role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001; 104: 1863-1867.
3. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of ArterialHypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219.
4. Ankle Brachial Index Collaboration, Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality. JAMA 2008; 300: 197-208.
5. Martyn CN, Gale CR, Jespersen S, Sherriff SB. Impaired fetal growth and atherosclerosis of carotid and peripheral arteries. Lancet 1998; 352: 173-178.
6. Busch MA, Lutz K, Rohl JE, Neuner B, Masuhr F. Low ankle-brachial index predicts cardiovascular risk after acute ischemic stroke or transient ischemic attack. Stroke 2009; 40: 3700-3705.
7. Kajikawa M, Maruhashi T, Iwamoto Y, Iwamoto A, Matsumoto T, Hidaka T, et al. Borderline ankle-brachial index value of 0.91–0.99 is associated with endothelial dysfunction. Circ J 2014; 78: 1740-1745.
8. Li S, Chen W, Srinivasan SR, Berenson GS. Influence of metabolic syndrome on arterial stiffness and its age-related change in young adults: The Bogalusa Heart Study. Atherosclerosis 2005; 180: 349-354.
9. Shimbo D, Grahame-Clarke C, Miyake Y, Rodriguez C, Sciacca R, Di Tullio M, et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007; 192: 197-203.
10. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness. J Am Coll Cardiol 2010; 55: 1318-1327.
11. Verbeke F, Marechal C, Van Laecke S, Van Biesen W, Devuyst O, Van Bortel LM, et al. Aortic stiffness and central wave reflections predict outcome in renal transplant recipients. Hypertension 2011; 58: 833-838.
12. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, et al. Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: The multi-ethnic study of atherosclerosis. Circulation 2009; 120: 502-509.
13. Matsuzawa Y, Guddeti RR, Kwon TG, Lerman LO, Lerman A. Secondary prevention strategy of cardiovascular disease using endothelial function testing. Circ J 2015; 79: 685-694.
14. Peralta CA, Shlipak MG, Fan D, Ordonez J, Lash JP, Chertow GM, et al. Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2892-2899.
15. Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
16. Turin TC, Kita Y, Rumana N, Takashima N, Kadota A, Matsui K, et al. Brachial-ankle pulse wave velocity predicts all-cause mortality in the general population: Findings from the Takashima study, Japan. Hypertens Res 2010; 33: 922-925.
17. Maebuchi D, Sakamoto M, Fuse J, Tanaka H, Shiraishi Y, Takei M, et al. The cardio-ankle vascular index predicts chronic kidney disease in Japanese subjects. Artery Research 2013; 7: 48-53.
18. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-265.
19. Makino H, Yasuda Y, Matsuo S. Challenges to chronic kidney disease in Japan: Japan Association of Chronic Kidney Disease Initiative (J-CKDI). Nihon Jinzo Gakkai Shi 2006; 48: 711-713 (in Japanese).
20. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res 2014; 37: 253-390.
21. Driver TH, Shlipak MG, Katz R, Goldenstein L, Sarnak MJ, Hoofnagle AN, et al. Low serum bicarbonate and kidney function decline: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2014; 64: 534-541.
22. Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
23. Cox AJ, Hsu FC, Carr JJ, Freedman BI, Bowden DW. Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study. Cardiovasc Diabetol 2013; 12: 68.
24. Guijarro C. High-sensitivity C-reactive protein: Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001; 104: E127.
25. Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 2004; 25: 17-24.
26. Gupta DK, Skali H, Claggett B, Kasabov R, Cheng S, Shah AM, et al. Heart failure risk across the spectrum of ankle-brachial index: The ARIC study (Atherosclerosis Risk In Communities). JACC Heart Fail 2014; 2: 447-454.
27. Kato A, Takita T, Furuhashi M, Maruyama Y, Miyajima H, Kumagai H. Brachial-ankle pulse wave velocity and the cardio-ankle vascular index as a predictor of cardiovascular outcomes in patients on regular hemodialysis. Ther Apher Dial 2012; 16: 232-241.
28. Shirai K, Saiki A, Nagayama D, Tatsuno I, Shimizu K, Takahashi M. The role of monitoring arterial stiffness with cardio-ankle vascular index in the control of lifestyle-related diseases. Pulse 2015; 3: 118-133.
29. Laucevičius A, Ryliškytė L, Balsytė J, Badarienė J, Puronaitė R, Navickas R, et al. Association of cardio-ankle vascular index with cardiovascular risk factors and cardiovascular events in metabolic syndrome patients. Medicina 2015; 51: 152-158.
30. Witte DR, Westerink J, de Koning EJ, van der Graaf Y, Grobbee DE, Bots ML. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? J Am Coll Cardiol 2005; 45: 1987-1993.
31. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, Elder GJ, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis. JAMA 2011; 305: 1119-1127.
32. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
33. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, et al. Aortic PWV in chronic kidney disease: A CRIC ancillary study. Am J Hypertens 2010; 23: 282-289.
34. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease: A cross-sectional study of predialysis, dialysis and kidneytransplantation patients. Atherosclerosis 2011; 216: 446-451.
35. Black CD, Vickerson B, McCully KK. Noninvasive assessment of vascular function in the posterior tibial artery of healthy humans. Dyn Med 2003; 2: 1.
36. Wang X, Qiu M, Qi J, Li J, Wang H, Li Y, et al. Impact of anemia on long-term ischemic events and bleeding events in patients undergoing percutaneous coronary intervention: A system review and meta-analysis. J Thorac Dis 2015; 7: 2041-2052.